Literature DB >> 17096344

High resolution tiling-path BAC array deletion mapping suggests commonly involved 3p21-p22 tumor suppressor genes in neuroblastoma and more frequent tumors.

Jasmien Hoebeeck1, Evi Michels, Björn Menten, Nadine Van Roy, Angelika Eggert, Alexander Schramm, Katleen De Preter, Nurten Yigit, Els De Smet, Anne De Paepe, Geneviève Laureys, Jo Vandesompele, Frank Speleman.   

Abstract

The recurrent loss of 3p segments in neuroblastoma suggests the implication of 1 or more tumor suppressor genes but thus far few efforts have been made to pinpoint their detailed chromosomal position. To achieve this goal, array-based comparative genomic hybridization was performed on a panel of 23 neuroblastoma cell lines and 75 primary tumors using a tiling-path bacterial artificial chromosome array for chromosome 3p. A total of 45 chromosome 3 losses were detected, including whole chromosome losses, large terminal deletions and interstitial deletions. The latter, observed in cell lines as well as a number of distal deletions detected in primary tumors, allowed us to demarcate 3 minimal regions of loss of 3.6 Mb [3p21.31-p21.2, shortest regions of overlap (SRO)1], 1.4 Mb (3p22.3-3p22.2, SRO2) and 3.8 Mb (3p25.3-p25.1, SRO3) in size. The present data significantly extend previous findings and now firmly establish critical regions on 3p implicated in neuroblastoma. Interestingly, the 2 proximal regions coincide with previously defined SROs on 3p21.3 in more frequent tumors including lung and breast cancer. As such, similar tumor suppressor genes may play a critical role in development or progression of a variety of neoplasms, including neuroblastoma.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17096344     DOI: 10.1002/ijc.22326

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  7 in total

1.  Combined Treatments with a Retinoid Receptor Agonist and Epigenetic Modulators in Human Neuroblastoma Cells.

Authors:  Viviane Rösner Almeida; Igor Araujo Vieira; Marienela Buendia; André Tesainer Brunetto; Lauro J Gregianin; Algemir Lunardi Brunetto; Fábio Klamt; Caroline Brunetto de Farias; Ana Lucia Abujamra; Patrícia Luciana da Costa Lopez; Rafael Roesler
Journal:  Mol Neurobiol       Date:  2016-11-10       Impact factor: 5.590

2.  Bioinformatics analysis of recurrent deletion regions in neuroblastoma.

Authors:  Hasan Onur Caglar
Journal:  Med Oncol       Date:  2022-01-20       Impact factor: 3.064

3.  Human fetal neuroblast and neuroblastoma transcriptome analysis confirms neuroblast origin and highlights neuroblastoma candidate genes.

Authors:  Katleen De Preter; Jo Vandesompele; Pierre Heimann; Nurten Yigit; Siv Beckman; Alexander Schramm; Angelika Eggert; Raymond L Stallings; Yves Benoit; Marleen Renard; Anne De Paepe; Geneviève Laureys; Sven Påhlman; Frank Speleman
Journal:  Genome Biol       Date:  2006       Impact factor: 13.583

4.  BAP1 induces cell death via interaction with 14-3-3 in neuroblastoma.

Authors:  Wondossen Sime; Qiankun Niu; Yasmin Abassi; Katarzyna Chmielarska Masoumi; Reihaneh Zarrizi; Julie Bonne Køhler; Sven Kjellström; Vito Alessandro Lasorsa; Mario Capasso; Haian Fu; Ramin Massoumi
Journal:  Cell Death Dis       Date:  2018-05-01       Impact factor: 8.469

5.  The emerging molecular pathogenesis of neuroblastoma: implications for improved risk assessment and targeted therapy.

Authors:  Nadine Van Roy; Katleen De Preter; Jasmien Hoebeeck; Tom Van Maerken; Filip Pattyn; Pieter Mestdagh; Joëlle Vermeulen; Jo Vandesompele; Frank Speleman
Journal:  Genome Med       Date:  2009-07-27       Impact factor: 11.117

6.  Genetic instability and intratumoral heterogeneity in neuroblastoma with MYCN amplification plus 11q deletion.

Authors:  Eva Villamón; Ana P Berbegall; Marta Piqueras; Irene Tadeo; Victoria Castel; Anna Djos; Tommy Martinsson; Samuel Navarro; Rosa Noguera
Journal:  PLoS One       Date:  2013-01-14       Impact factor: 3.240

7.  High-resolution array copy number analyses for detection of deletion, gain, amplification and copy-neutral LOH in primary neuroblastoma tumors: four cases of homozygous deletions of the CDKN2A gene.

Authors:  Helena Carén; Jennie Erichsen; Linda Olsson; Charlotta Enerbäck; Rose-Marie Sjöberg; Jonas Abrahamsson; Per Kogner; Tommy Martinsson
Journal:  BMC Genomics       Date:  2008-07-29       Impact factor: 3.969

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.